Oct 19, 2023, 09:04 AM by

Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050

Oct 19, 2023, 09:04 AM by

Oct 19, 2023, 09:04 AM by

Oct 19, 2023, 09:04 AM by

Oct 19, 2023, 09:04 AM by

BOC Sciences will attend "TIDES Europe: Oligonucleotide & Peptide Therapeutics", delivered as a hybrid event from 30 Oct - 1 Nov 2023, in Amsterdam, NL. Its high-yield nucleosides & nucleotides, as well as a newly launched XDC platform, will be exhibited in front of the industry.

Oct 19, 2023, 09:03 AM by

Biotium has announced the launch of its breakthrough BactoView™ Dead Stains and BactoView™ Viability Kits.

Oct 19, 2023, 09:03 AM by

Partnership Enables Healthcare Organizations to Leverage Unique Risk Advisory Services and Purpose-Built Workflow Automation to Maximize Cyber Risk Reduction

Oct 19, 2023, 09:03 AM by

Oct 19, 2023, 09:03 AM by

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) has signed an agreement to expand its collaboration with the Netherlands Cancer Institute (NKI) and Oncode Institute to study drug synergies of LIXTE’s lead clinical compound, LB-100, with immunotherapy in various cancers. The new agreement also will seek to find synthetic lethal combinations in additional cancer types.

Oct 19, 2023, 09:03 AM by

Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations

Oct 18, 2023, 08:59 AM by

Servier partners with Owkin with the aim of discovering and developing AI-driven precision therapeutics. The multi-year agreement will use Owkin’s sophisticated AI to potentially enable Servier to develop novel therapeutics across various disease areas.

Oct 18, 2023, 08:59 AM by

Oct 18, 2023, 01:00 AM by User Not Found

Bio-IT World| A new preclinical system put to the test by a network of labs to adaptively study a handful of stroke treatments has succeeded in demonstrating that high-quality science is “feasible, practical, and less expensive than doing things the wrong way.”

Oct 17, 2023, 08:34 AM by

Oct 17, 2023, 08:34 AM by

Oct 17, 2023, 08:30 AM by

Discovery Park, Kent’s thriving life science community, has partnered with scientific content discovery and discussion platform, Researcher, to promote collaboration and facilitate scientific progress.

Oct 17, 2023, 08:30 AM by

ISPE has recognized Genentech as the 2023 Facility of the Year Awards (FOYA) Overall Winner for the Clinical Supply Center (CSC) project located in South San Francisco, California, USA.

Oct 16, 2023, 14:23 PM by User Not Found

Bio-IT World| The European Commission (EC), under the EU Merger Regulation (EUMR), released a statement last week announcing it has taken restorative measures that require Illumina to unwind its acquisition of GRAIL. The acquisition was completed before the EC provided approval, breaching EU merger control rules.

Oct 16, 2023, 08:50 AM by

When cfDNA testing result is negative or patients become unresponsive/resistant to current existing treatment strategy, plasma-based cfmRNA testing (ie., OncoDxRx’s PGA assay) can help clinicians to select the most effective therapy available within 5 days. Particularly in advanced cases of cancer, wait times associated with complex NGS testing of cfDNA can significantly impact a patient’s time to treatment and overall outcome.

Oct 16, 2023, 08:50 AM by